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Background: Glutamatergic receptor [N-methyl-d-aspartate receptor (NMDAR)] alter-
ations within cortex, hippocampus, and striatum are linked to schizophrenia pathology. 
Maternal immune activation (MIA) is an environmental risk factor for the development 
of schizophrenia in offspring. In rodents, gestational timing of MIA may result in distinct 
behavioral outcomes in adulthood, but how timing of MIA may impact the nature and 
extent of NMDAR-related changes in brain is not known. We hypothesize that NMDAR-
related molecular changes in rat cortex, striatum, and hippocampus are induced by MIA 
and are dependent on the timing of gestational inflammation and sex of the offspring.
Methods: Wistar dams were treated the with viral mimic, polyriboinosinic:polyribocytidy-
lic acid (polyI:C), or vehicle on either gestational day 10 or 19. Fresh-frozen coronal brain 
sections were collected from offspring between postnatal day 63–91. Autoradiographic 
binding was used to infer levels of the NMDAR channel, and NR2A and NR2B subunits 
in cortex [cingulate (Cg), motor, auditory], hippocampus (dentate gyrus, cornu ammonis 
area 3, cornu ammonis area 1), and striatum [dorsal striatum, nucleus accumbens core, 
and nucleus accumbens shell (AS)]. NR1 and NR2A mRNA levels were measured by 
in situ hybridization in cortex, hippocampus, and striatum in male offspring only.
results: In the total sample, NMDAR channel binding was elevated in the Cg of polyI:C 
offspring. NR2A binding was elevated, while NR2B binding was unchanged, in all brain 
regions of polyI:C offspring overall. Male, but not female, polyI:C offspring exhibited 
increased NMDAR channel and NR2A binding in the striatum overall, and increased 
Abbreviations: Aud, auditory cortex; Cg, cingulate cortex; DS, dorsal striatum; M1, motor cortex; MIA, maternal immune acti-
vation; AC, nucleus accumbens core; AS, nucleus accumbens shell; DG, dentage gyrus; CA1, cornu ammonis area 1; CA3, cornu 
ammonis area 3; so, stratum oriens; sr, stratum radiatum; PBS, phosphate-buffered saline; NMDAR, N-methyl-d-aspartate 
receptor; polyI:C, polyriboinosinic:polyribocytidilic acid; GD, gestational day; PND, postnatal day; RM-ANOVA, repeated 
measures two-way analysis of variance.
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NR2A binding in the cortex overall. Male polyI:C offspring exhibited increased NR1 mRNA 
in the AS, and increased NR2A mRNA in cortex and subregions of the hippocampus.
conclusion: MIA may alter glutamatergic signaling in cortical and hippocampal regions 
via alterations in NMDAR indices; however, this was independent of gestational timing. 
Male MIA offspring have exaggerated changes in NMDAR compared to females in 
both the cortex and striatum. The MIA-induced increase in NR2A may decrease brain 
plasticity and contribute to the exacerbated behavioral changes reported in males and 
indicate that the brains of male offspring are more susceptible to long-lasting changes in 
glutamate neurotransmission induced by developmental inflammation.
Keywords: striatum, nMDa, polyriboinosinic:polyribocytidylic acid, maternal immune activation, Wistar rat, 
schizophrenia, rat model
inTrODUcTiOn
Epidemiological investigations implicate gestational inflammation 
as a significant risk factor in the manifestation of psychiatric dis-
orders, including schizophrenia, in offspring (1). Studies suggest 
either the first (2) or second (1) trimester as the critical window 
of vulnerability for maternal infection to increase schizophrenia 
risk in people. Maternal immune activation (MIA), as modeled 
in rodents and non-human primates, suggests pro-inflammatory 
cytokines that result from MIA, rather than the pathogen itself, are 
critical in the development of schizophrenia-like behaviors and 
neuropathology in adult offspring (3–6). Deficits in sensorimotor 
gating and working memory are prevalent in schizophrenia (7, 8) 
and found in MIA rodents. The use of MIA in animal models has 
therefore been pivotal to establish a causal link between gestational 
inflammation and the development of neuropsychiatric-related 
phenotypes; however, only limited changes in brain cytokines are 
still found in the adult (9), suggesting that molecular alterations 
in neurotransmitter pathways including monoamines (10, 11) 
and GABA (12) may be more long lasting. Since pharmacologi-
cal manipulations of glutamate neurotransmission are known to 
cause deficits in sensorimotor gating and in working memory, 
which are reminiscent of changes found in schizophrenia, we 
predict that widespread changes in glutamate receptors may be 
found in adult offspring of mothers who experienced immune 
activation while pregnant. While there is a report of a reduction 
in one subunit of the N-methyl-d-aspartate receptor (NMDAR) 
in one brain region (the hippocampus) (13), there are still 
gaps in our knowledge regarding the putative changes in other 
NMDAR subunits and the extent of NMDAR changes outside 
the hippocampus. It is important to determine the nature and 
extent of NMDAR changes more fully to not only correlate them 
with behavior but to also aid in the design of treatments aimed 
to either prevent or ameliorate changes in NMDAR-mediated 
neurotransmission that may underlie symptoms and cognitive 
deficits resulting from developmental overactivation of the 
immune system. This knowledge will expand our understanding 
of how gestational inflammation impacts glutamatergic signaling 
in psychiatric disorders with a neurodevelopmental etiology.
The timing of MIA can elicit specific behavioral phenotypes in 
rodent offspring during development and adulthood (6, 14). This 
phenomenon has been demonstrated in a mouse model that used 
the viral mimic, synthetic double-stranded RNA polyriboinosin
ic:polyribocytidilic acid (polyI:C, henceforth polyI:C offspring). 
Early polyI:C exposure on gestational day (GD) 9 results in adult 
offspring with behaviors that are used to index schizophrenia-like 
behaviors, such as sensorimotor gating deficits (13) and primar-
ily dopaminergic-related behavioral alterations concomitant 
with a reduction in dopamine receptor D1 levels in cortex 
(13, 15, 16). Late polyI:C exposure on GD17 results in offspring 
with behavioral changes consistent with schizophrenia-like 
deficits in cognitive function, including working memory and 
reversal learning deficits (13, 17). Late polyI:C exposure results in 
offspring with changes in the hippocampus that include NMDAR-
related alterations (13). In rats, mid-late gestation (GD14–17) 
MIA produces a range of schizophrenia-like phenotypes that 
include both increased and decreased locomotor response to the 
NMDAR antagonist MK-801 (18–21), deficits in sensorimotor 
gating (22–25), impaired cognition (23, 26), and reduced brain 
volume in cortical, hippocampal, and striatal regions (27, 28). We 
have recently reported that early (GD10) and late (GD19) MIA in 
rats, at developmentally equivalent times to mice (29), may not 
result in differential schizophrenia-like behaviors. We found that 
males with early polyI:C exhibit sensorimotor gating deficits and 
that males with late (GD19) polyI:C exhibit sensorimotor gating 
and working memory deficits (30), suggesting that there may be 
long-lasting alterations in cortical glutamate neurotransmission 
especially after late MIA.
A key glutamate receptor involved in learning and memory is 
the NMDAR. NMDAR hypofunction is a prevailing hypothesis 
in the pathophysiology of schizophrenia (31) and NMDAR1 
is reduced in the frontal cortex of people with schizophrenia 
compared to controls (32). NMDARs are ionotropic glutamate 
receptors essential for synaptic plasticity throughout the brain 
(33). NMDARs consist of two obligatory NR1 subunits and two 
regulatory subunits (i.e., NR2A and/or NR2B) functioning as a 
membrane heterotetramer (34). NR2B-rich NMDARs predomi-
nate throughout the brain during early development, and NR2A-
containing NMDARs gradually increase expression after birth 
(34). NMDARs rich in NR2A have shorter channel opening time 
and an increased probability to open compared to NR2B-rich 
NMDARs (35, 36). Additionally, the ratio between NR2A- and 
NR2B-containing NMDARs in the hippocampus is critical in 
activity-dependent plasticity, where increased NR2A:NR2B is 
FigUre 1 | Regions within coronal rat sections used for autoradiographic 
binding and in situ hybridization. (a–D) Solid gray polygons outlined in black 
depict cortical subregions quantified: cingulate [(a,B) solid line], motor [(a,B) 
short dashed line], and auditory [(c,D) long dashed line]. (c,D) Hippocampus 
is enlarged to delineate subregions, where black lines depict: dentate gyrus 
(solid line), cornu ammonis field 3 (short dashed line), and cornu ammonis 
field 1 (long dashed line). Shaded regions indicate levels quantified for binding 
data: afferent (dark gray; molecular layer, stratum radiatum) and efferent (light 
gray; polymorph layer, stratum oriens). (a,B) Empty black outlines depict 
striatal subregions quantified: dorsal striatum (solid line), nucleus accumbens 
core (short dashed line), and nucleus accumbens shell (long dashed line). 
Text in gray indicates Bregma level of section. Adapted from Paxinos and 
Watson sixth edition Rat Atlas (41).
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associated with less plasticity and reduced signal transduction 
(37–39). PolyI:C offspring exhibit decreased neonatal neuronal 
excitability (40), and decreased NR1 immunoreactivity (13) and 
synaptic plasticity in the hippocampus in adulthood. The extent 
to which other NMDAR regulatory subunits (2A and 2B) are 
changed due to MIA and the relationship of NMDAR changes to 
the time of exposure and sex of the offspring will provide informa-
tion needed to help design ways to ameliorate the neurobiological 
impact of MIA.
In the current study, we sought to elucidate the effects of 
early (GD10) versus late (GD19) polyI:C treatment on NMDA 
receptor subunits in a range of cortical, hippocampal, and striatal 
subregions of male and female adult offspring. We hypothesize 
that MIA will induce NMDAR-related molecular changes in rat 
cortex, striatum, and hippocampus in adult offspring and changes 
will be dependent both on the timing of gestational inflammation 
and the sex of the offspring. We specifically aimed to extend the 
scope of previous MIA studies, which examined NR1 mRNA only 
(13), to include quantitative binding assays of the whole NMDA 
channel, and NR2A and NR2B subunits. As our largest changes 
were primarily NMDAR binding alterations in male polyI:C off-
spring, we investigated related mRNAs in the same brain regions 
from male offspring only.
MaTerials anD MeThODs
animals and Prenatal Polyi:c 
administration
Experiments were performed in accordance with the National 
Health and Medical Research Council’s Australian code for the 
care and use of animals for scientific purposes. The current study 
was approved by the University of Newcastle’s Animal Care and 
Ethics Committee (Approval number A-2009-108). Rats were 
sourced from the University of Newcastle’s Central Animal 
House and housed with ad libitum food and water and 12 h light 
exposure in the University of Newcastle’s Behavioral Sciences 
Animal Facility.
Postnatal day (PND) 70–90 Wistar rats were time-mated and 
day of vaginal plug detection was designated as GD0. Pregnant 
rats were assigned to two groups: GD10 (control, n = 8) or GD19 
(n =  7). On the appropriate GD, pregnant rats were weighed, 
lightly anesthetized with isoflurane, and injected intravenously 
through the tail vein with 0.1 M phosphate-buffered saline (PBS) 
(control; n = 8) or 4 mg/mL of polyI:C (P9582, Sigma-Aldrich; 
n = 7) in PBS at a volume of 1 mL/kg body weight. To confirm 
successful MIA, saphenous vein blood samples were collected 2 h 
after treatment injections. Plasma was used for interleukin-6 (IL-
6) measurement using rat IL-6 Quantikine ELISA (R&D Systems, 
MN, USA). PolyI:C treated dams had significantly increased IL-6 
levels (624.7 ±  57.0  pg/mL) compared to saline-injected dams 
(68.4 ±  57.0 pg/mL) [F(1,8) =  47.646, p <  0.001]. There was no 
effect of gestational timing [F(1,8) = 0.218, p > 0.05] or interaction 
between gestational timing and treatment [F(1,8) = 0.211, p > 0.05] 
on maternal plasma IL-6 levels (data not shown).
Offspring were weaned on PND 21, separated into same-sex 
cages in pairs, and euthanized by isoflurane anesthesia and 
decapitation between PND 63–91 (n = 6–8 for each subgroup). 
At time of euthanasia, there was no effect of treatment on weight 
between control (350 ± 6 g) and polyI:C offspring (341 ± 7 g) 
[F(1,50) =  0.975, p >  0.05]. There was a significant effect of sex 
on weight where female offspring (264 ± 6 g) weighed less than 
males (426 ± 7 g) [F(1,50) = 302.0, p < 0.05]. There were no other 
TaBle 2 | In situ hybridization riboprobe details.
Target gene Bp region from origin (0) lOcUs iD autoradiographic exposure time on film (days) specific activity (cpm/μg) of 
riboprobe
sense (+) antisense (−)
GRIN1 (NR1) 1,840–2,081 NM_008169.3 10 1.69 × 109 1.42 × 109
GRIN2A (NR2A) 3,218–3,418 NM_000833.2 21 1.61 × 109 1.87 × 109
TaBle 1 | Summary of autoradiographic binding methods.






2.5 h at RT 20 µM non-tritiated 
MK-801 (Sigma)
2 × 20 min at 4°C
30 mM HEPES buffer with 100 µM glycine, 100 µM glutamate, 1 mM 
EDTA, and 20 nM [3H]MK-801 (s.a. 17.1 Ci/mmol, PerkinElmer, USA),  
pH 7.5
30 mM HEPES buffer with 
1 mM EDTA, pH 7.5
[3H]CGP39653 (43) 
(NR2A subunit)
45 min at RT 45 min at RT 1 mM l-glutamic acid 30 s at 4°C
50 mM Tris–HCl, 
pH 8
50 mM Tris–HCl with 20 nM [3H]CGP39653, pH 8 50 mM Tris–HCl, pH 8
[3H]Ifenprodil  
(NRB subunit)
3 h at 4°C 10 µM non-tritiated 
Ifenprodil
3 × 5 min at 4°C
50 mM Tris–HCI buffer with 3 μM R(+)-3-(3-hydroxyphenyl)-N-
propylpiperidine hydrochloride, 30 µM GBR-12909, 100 µM 20 nM [3H]
Ifenprodil trifluoperazine, pH 7.4
50 mM Tris–HCl buffer, 
pH 7.4
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interaction effects [F(1,50) < 1.50, p > 0.05; data not shown]. Whole 
brains were snap-frozen in isopentane at −40°C and stored at 
−80°C. Coronal sections (14 µm; Figure 1) were prepared using 
a cryostat (Leica, Wetzlar, Germany) and mounted onto gelatin-
coated glass slides.
In Situ radioligand Binding
Receptors were identified using autoradiography and tritiated 
specific ligands. Following the autoradiographic assays (Table 1), 
slides were dipped in ice-cold distilled H2O, dried in a stream 
of cold air, and exposed to BioMax MR (Kodak, Rochester, NY, 
USA) autoradiographic film for 75 ([3H]MK-801), 76 ([3H]
CGP39653), or 69 ([3H]Ifenprodil) days with tritium standards 
(American Radiolabeled Chemicals, St. Louis, MO, USA). Films 
were developed using standard procedures.
Quantification of autoradiographic images
Developed films were digitized and calibrated using the NIH 
imaging software (v1.561) to produce nCi/mg tissue equivalent 
values based on the standard Rodbard curve obtained from the 
3H standards (American Radiolabeled Chemicals, St. Louis, MO, 
USA). Optical density values were quantitated using ImageJ 
(v1.482). Non-specific binding was at background levels for all 
ligands examined; therefore, total binding values were aver-
aged from between two and four consecutive sections for each 
measure. Cortical [cingulate (Cg), motor (M1), auditory (Aud)], 
hippocampal [dentate gyrus (DG), cornu ammonis area 3 (CA3), 
cornu ammonis area 1 (CA1)], and striatal [dorsal striatum (DS), 
1 http://rsb.info.nih.gov/nih-image.
2 https://imagej.nih.gov/ij/.
nucleus accumbens core (AC), nucleus accumbens shell (AS)] 
regions were quantified (Figure  1). For hippocampus, afferent 
and efferent (neuropil) regions were quantified for binding, while 
the soma layer was quantified for mRNA. All brain regions were 
identified as per Paxinos and Watson sixth edition Rat Atlas (41).
In Situ hybridization
Sections from control and MIA male offspring were investigated 
for related mRNAs. Riboprobes (Table 2) were generated with 35S-
UTP (PerkinElmer) using an in vitro transcription kit (Promega, 
Madison, WI, USA). In situ hybridization was performed as 
previously described (44), using 5 ng/mL radiolabeled riboprobes 
in hybridization buffer, and 35S-UTP labeled sense riboprobes as 
a negative control. Slides were exposed to BioMax MR (Kodak, 
Rochester, NY, USA) autoradiographic film (details in Table 2) 
alongside a 14C standard slide (American Radiolabeled Chemicals, 
St. Louis, MO, USA). Quantification of mRNAs was completed 
as mentioned above (see Quantification of Autoradiographic 
Images) with the standard Rodbard curve from the 14C standard 
slide.
statistical analysis
Analysis was performed with IBM SPSS statistics (v23). Graphs 
were plotted using GraphPad Prism (v6). Data for each measure in 
each region (cortex, hippocampus, striatum) were analyzed using 
repeated measures two-way analysis of variance (RM-ANOVA) 
separately. Within-subject factors were the three subregions. 
Between-subject factors were prenatal treatment (polyI:C or vehi-
cle), offspring sex (male or female), and gestational timing (GD10 
or GD19) for the binding, and prenatal and gestational timing 
for the mRNAs (in male offspring only). Fisher’s least significant 
differences were used for pairwise comparisons by treatment 
FigUre 2 | Representative autoradiographs of regions from maternal 
immune activation offspring. Coronal sections from adult (postnatal day 
63–91) male offspring from vehicle (control: a,c) or polyI:C (b,d) treated dams 
were processed with tritiated radioligands to detect (a) N-methyl-d-aspartate 
receptor (NMDAR) channel (MK-801), (B) NR2A (CGP39653), and (c) NR2B 
(Ifenprodil) binding in (a,b: ~2.50 mm bregma) cortical, striatal, and (c,d: 
~−3.10 mm bregma) hippocampal regions. (a) PolyI:C offspring showed 
significantly increased NMDAR channel binding in (a,b) cingulate and 
striatum, but not (c,d) hippocampal regions. (B) PolyI:C offspring showed 
significant increases in NR2A binding overall in all quantified regions.  
(c) PolyI:C offspring showed no significant change in NR2B binding  
overall in any quantified region. Scale bars represent 500 µm.
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when ANOVA analyses were significant. The Greenhouse Geisser 
correction was used if Mauchley’s sphericity test was violated for 
within-subjects interaction effects. Overall treatment effects or 
effects of sex, region, or GD of exposure are presented graphi-
cally only when a significant effect or interaction was identified. 
In all cases, data are expressed as the mean ± SEM and p ≤ 0.05 
was deemed statistically significant. NR2A:NR2B ratio for hip-
pocampus was calculated by division of [3H]CGP39653 binding 
values (NR2A subunit) with [3H]Ifenprodil binding values (NR2B 
subunit) in each subregion and level for each animal.
resUlTs
effect of Maternal Polyi:c Treatment and 
Timing on ligand Binding in adult Male 
and Female Offspring
Representative autoradiographs of binding assays are shown in 
Figure  2 and show the expected pattern of NMDAR channel, 
NR2A subunit, and NR2B subunit (Figures 2A–C, respectively) 
binding and distribution in rodent brain (45–47). Briefly, signals 
are evenly distributed across the cortex and striatum. White mat-
ter tracts (i.e., corpus callosum) are not labeled and hippocampal 
architecture including neuropil areas surrounding ammon’s horns 
region are labeled. Overall, autoradiographic signals were less in 
cortex and striatum (a,b) in comparison to hippocampus (c,d).
[3H]MK-801 Binding (NMDAR Channel)
Although there was no overall effect of polyI:C on NMDAR 
channel binding ([3H]MK-801 binding) in the cortex [Treatment 
effect: F(1,45)  =  1.86, p  >  0.10], polyI:C offspring had ~13% 
more NMDAR channel expression than control offspring in Cg 
[Treatment ×  Subregion effect: F(2,90) =  3.27, p <  0.05; Control 
versus polyI:C in cingulate: F(1,45) = 5.34, p < 0.05; Figures 2A and 
3A]. PolyI:C did not affect NMDAR channel binding in the M1 or 
Aud (Figure 3A). PolyI:C did not affect NMDAR channel bind-
ing in the hippocampus [Treatment effect: F(1,45) = 1.13, p > 0.10; 
Figure 2A; Table 3]. There was no effect of offspring sex or GD 
of exposure on NMDAR channel binding in either the cortex or 
the hippocampus [both, F(1,42) < 2.65, p > 0.10].
In the striatum, polyI:C offspring had ~20% more NMDAR 
channel binding than control offspring [Treatment effect: 
F(1,45) = 17.63, p < 0.001; Table 3; Figure 2A]. In addition, male 
polyI:C offspring had ~34% more NMDAR channel binding 
than male control offspring [Treatment × Sex effect: F(1,45) = 6.68, 
p < 0.05; Pairwise contrast: F(1,45) = 22.68, p < 0.001; Figure 3B]. 
No change was observed in polyI:C-exposed compared to control 
females [F(1,45) = 1.322, p > 0.05; Figure 3B]. There was no effect 
of GD of exposure on NMDAR channel binding in the striatum 
[F(1,45) = 3.473, p < 0.10].
[3H]CGP39653 Binding (NR2A Subunit)
In total hippocampus, polyI:C offspring had ~30% more NR2A 
binding than control offspring [Treatment effect: F(1,44) =  6.22, 
p <  0.05; Table  3; Figure  2B], the magnitude of this increase 
was moderate to strong (31–44% increases) in all subregions 
[Treatment × Subregion × Level effect: F(1.7,45) = 3.68, p < 0.05; 
Pairwise contrasts: F(1,44) >  5.41, p <  0.05; Figure  4A] except 
the molecular layer of the DG [Pairwise contrast: F(1,44) = 2.74, 
p > 0.10; Figure 4A]. There was no effect of gestation day of expo-
sure on NR2A binding in the hippocampus, cortex, or striatum 
[F(1,45–47) < 0.178, p > 0.10].
Overall, polyI:C offspring had ~57% more NR2A binding than 
control offspring in the cortex [Treatment effect: F(1,45) = 11.004, 
p < 0.01; Table 3; Figure 2B]. In addition, we detected a sex by 
treatment interaction effect, where male polyI:C offspring had 
TaBle 3 | Overall effect of gestational polyI:C exposure on NMDA receptor channel and subunit binding.
Binding (fmol/mg tissue equivalent) Mean ± seM (n)
control Maternal immune activation Treatment effect
N-methyl-d-aspartate receptor channel [3H]MK-801 Cortex 7.33 ± 0.29 (30) 7.87 ± 0.28 (23) F(1,45) = 1.86, p > 0.10
Hippocampus 8.74 ± 0.3 (30) 9.15 ± 0.27 (23) F(1,45) = 1.13, p > 0.10
Striatum 6.5 ± 0.23 (29) 7.62 ± 0.27 (25)*** F(1,45) = 17.63, p < 0.001
NR2A [3H]CGP39653 Cortex 2.69 ± 0.31 (28) 4.24 ± 0.36 (25)** F(1,45) = 11.004, p < 0.01
Hippocampus 4.05 ± 0.28 (28) 5.3 ± 0.42 (25)* F(1,44) = 6.22, p < 0.05
Striatum 1.69 ± 0.14 (26) 2.3 ± 0.22 (25)* F(1,47) = 6.62, p < 0.05
NR2B [3H]Ifenprodil Cortex 11.03 ± 0.36 (31) 10.77 ± 0.32 (27) F(1,50) = 0.24, p > 0.10
Hippocampus 13.81 ± 0.38 (31) 13.58 ± 0.35 (25) F(1,48) = 0.11, p > 0.10




FigUre 3 | N-methyl-d-aspartate receptor (NMDAR) channel binding alterations in cortex and striatum from adult offspring exposed to vehicle (control; black) or 
polyI:C (gray) during early (GD10) or late (GD19) gestation. Tritiated MK-801 binding was used to quantify NMDAR channel levels. Significantly increased NMDAR 
binding was found in the cingulate subregion of polyI:C offspring compared to controls (a). Male, but not female, polyI:C offspring specifically exhibited significantly 
increased NMDAR channel binding in the striatum (B). Bars represent mean ± SEM (n = 15–28 rats per group). Cg, cingulate cortex; M1, motor cortex; Aud, 
auditory cortex (*p < 0.05, ***p < 0.001).
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~132% more NR2A binding than male control offspring in corti-
cal tissue [Treatment × Sex effect: F(1,45) = 4.794, p < 0.05; Pairwise 
contrast: F(1,42) = 24.61, p < 0.001; Figure 4B], an effect that was 
not observed for females [F(1,45) = 0.483, p > 0.10; Figure 4B].
Overall, polyI:C offspring had ~43% more NR2A binding than 
control offspring in the striatum [Treatment effect: F(1,47) = 6.62, 
p <  0.05; Table  3; Figure  2B]. Similar to the cortex, polyI:C-
exposed male offspring had ~86% more NR2A binding than male 
control offspring [Treatment × Sex effect: F(1,47) = 5.38, p < 0.05; 
Pairwise comparison: F(1,47) =  11.79, p <  0.01; Figure  4C], an 
effect which was not observed in females [F(1,45) = 0.03, p > 0.10; 
Figure 4C].
[3H]Ifenprodil Binding (NR2B Subunit)
There was a consistent lack of change in [3H]Ifenprodil expres-
sion across all regions in polyI:C offspring compared to control 
offspring (Table 3; Figure 2C). There was no effect of treatment, or 
any interaction of treatment with offspring sex, GD of exposure, or 
anatomical region in the cortex [all F(1,50) and F(2,100) < 0.50, p > 0.10; 
Table 3; Figure 2C], hippocampus [all F(1,48) < 0.40, F(1.4,62.8) < 1.50, 
F(2,96) < 2.21, p > 0.10; Table 3; Figure 2C], or striatum [all F(1,47) 
and F(2,94) < 0.50, p > 0.05; Table 3; Figure 2C] on NR2B binding.
NR2A:NR2B Ratio in Hippocampus
PolyI:C offspring had ~31% increased NR2A:NR2B ratio 
compared to control offspring [Treatment effect: F(1,46) =  5.40, 
p < 0.05; Figure 5A]. In addition, compared to control offspring, 
polyI:C offspring had ~25% higher NR2A:NR2B ratio in hip-
pocampal afferent levels [F(1,46) = 4.35, p < 0.05] and ~38% higher 
NR2A:NR2B ratio in hippocampal efferent levels [F(1,46) = 6.37, 
p  <  0.05] than control offspring [Treatment  ×  Level effect: 
F(1,46) = 5.09, p < 0.05; Figure 5B].
effect of Maternal Polyi:c Treatment on 
nr1 and nr2a mrna in adult Male 
Offspring
Representative in  situ autoradiographs are shown in Figure  6 
and the expected pattern of NR1 mRNA (GRIN1, Figure  6A) 
FigUre 4 | NR2A subunit binding alterations in hippocampus, cortex, and striatum from adult offspring exposed to vehicle (control; black) or polyI:C (gray) during 
early (GD10) or late (GD19) gestation. Tritiated CGP39653 was used to quantify NR2A subunit levels. PolyI:C offspring had significantly increased NR2A binding in all 
hippocampal subregional levels, except the DGmo (a). Male, but not female, rats exposed to polyI:C during gestation had increased NR2A binding in the cortex (B) 
and striatum (c). Bars represent mean ± SEM (n = 15–28 rats per group). DGmo, molecular layer of dentate gyrus; CA3sr, stratum radiatum of cornu ammonis 3; 
CA1sr, stratum radiatum of cornu ammonis 1; DGpo, polymorph layer of dentate gyrus; CA3so, stratum oriens of cornu ammonis 3; CA1so, stratum oriens of cornu 
ammonis 1 (*p < 0.05, **p < 0.01, ***p < 0.001).
FigUre 5 | NR2A:NR2B binding ratio in hippocampus of adult offspring 
exposed to vehicle (control; black) or polyI:C (gray) during early (GD10) or late 
(GD19) gestation. Tritiated CGP39653 and Ifenprodil were used to calculate 
the ratio of NR2A:NR2B subunit binding. (a) The ratio of NR2A:NR2B ratio 
binding in the hippocampus was significantly increased in polyI:C offspring. 
(B) This increased ratio was elevated at both afferent and efferent levels of 
each hippocampal subregion. Bars represent mean ± SEM (n = 25–28 rats 
per group) (*p < 0.05).
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and NR2A mRNA (GRIN2A, Figure 6B) distribution was identi-
fied in rodent brain (37). Briefly, signals were evenly distributed 
across the cortex and striatum (a,b). In the hippocampus, the 
granular layer of the DG and the pyramidal neuronal layers 
within ammons-horn (CA3–CA1) were darkly labeled for both 
NMDAR1 and NMDAR2A mRNAs (c,d), whereas the hilar region 
of CA4 had intermediate levels of both mRNAs. NR2A mRNA 
(Figure 6B) was less in the striatum relative to the cortex (a,b). 
White matter tracts were clearly identifiable (corpus callosum and 
anterior commissure) with no mRNA signal. Overall, all autora-
diographic signals were less intense and more homogenous in 
cortex and striatum (a,b) in comparison to the hippocampus (c,d).
Maternal immune activation did not affect NR1 mRNA levels 
in cortical tissue [all Treatment effects/interactions: F(1,22) < 2.88, 
p > 0.05; Figures 6A and 7A]. Similarly, no treatment main effects 
or interactions were observed for NR1 mRNA in hippocampus 
[all F(1,24) < 2.64, all F(1.4,24) < 1.0, p > 0.05; Figure 7A]. In the stria-
tum, polyI:C offspring had a small, but statistically significant, 
increase (~11%) in NR1 mRNA in the AS compared to controls 
[Treatment × Subregion: F(2,44) = 6.08, p < 0.01; Pairwise contrast: 
F(1,22) = 8.11, p < 0.01; Figures 6B and 7B].
In contrast to the overall lack of large changes in NR1 mRNA, 
polyI:C offspring had widespread increases in NR2A mRNA. 
Compared to controls, polyI:C offspring had ~25% more NR2A 
mRNA in cortex [Treatment effect: F(1,24) = 4.20, p < 0.05] and 
~22% more NR2A mRNA in hippocampus [Treatment effect: 
F(1,24) = 9.02, p < 0.01; Figures 6B and 7C]. In addition, polyI:C 
offspring had ~18% more NR2A mRNA in DG [F(1,24) =  4.53, 
p < 0.05], and ~29% more NR2A mRNA in CA1 [F(1,49) = 16.61, 
FigUre 6 | Representative in situ hybridization films of N-methyl-d-aspartate 
receptor subunit gene expression in brain regions from male polyI:C offspring. 
Coronal sections from adult (postnatal day 63–91) male offspring from vehicle 
(control: a,c) or polyI:C (b,d) treated dams were processed to detect (a) 
GRIN1 (NR1) and (B) GRIN2A (NR2A) mRNA in (a,b: ~2.30 mm bregma) 
cortical, striatal and (c,d: ~−3.10 mm bregma) hippocampal regions. (a) 
PolyI:C offspring showed significant increases in NR1 mRNA in (a,b) nucleus 
accumbens shell (red arrows), with no significant changes in cortex or (c,d) 
hippocampus. (B) PolyI:C offspring showed (a,b) no significant change in 
NR2A mRNA in striatum, but significantly elevated NR2A mRNA in cortex 
(red arrowheads) and (c,d) hippocampal regions. Scale bars represent 
500 µm.
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p < 0.01; Subregion × Treatment effect: F(2,48) = 3.28, p < 0.05; 
Figures  6B and 7D]. The increase of NR2A mRNA in CA3 
of polyI:C offspring did not reach significance [F(1,24)  =  3.32, 
p < 0.10] (Figure 7D). In striatal tissue, there was no significant 
treatment or between-groups interaction effect [F(1,23)  <  3.15, 
p > 0.05; Figures 6B and 7C].
DiscUssiOn
We found NMDAR-related molecular alterations in multiple 
brain regions from polyI:C offspring that potentially could 
contribute to early and late MIA behavioral changes previously 
reported in this model. However, contrary to our expectations, 
we did not find any interaction effects between the impact of MIA 
and GD. Additionally, while we would have expected decreased 
NMDAR binding overall, we found increased NMDAR channel 
binding, specifically in the Cg of polyI:C offspring. We also found 
novel and widespread increases in NR2A binding supported by 
significant increases in NR2A mRNA, along with no changes 
in NR2B binding, in polyI:C offspring. As hypothesized, we 
found more exaggerated molecular alterations in male polyI:C 
offspring, compared to female polyI:C offspring. Thus, we 
found that MIA elicited coordinated NMDAR alterations that 
were primarily in male offspring, in line with the exaggerated 
behavioral change found in males after MIA in our previous 
investigation (30).
Our most robust finding was increased NR2A binding in 
the brain of adult male polyI:C offspring. NR2A-rich NMDARs 
have relatively shorter channel opening duration (38), and 
faster decay kinetics (37, 48). We did not detect corresponding 
altered NMDAR channel binding in the hippocampus of polyI:C 
offspring, suggesting that more NMDARs would be of the NR1–
NR2A containing type but may not be dramatically changed 
in overall numbers. This concurs with our finding of increased 
NR2A mRNA, and no change in NR1 mRNA, in several brain 
regions. The lack of interaction between treatment and gestational 
timing indicates that hippocampal NMDARs are potentially 
vulnerable to MIA at either gestational stage and suggests that 
increases in NMDAR2A could be a common brain response to 
developmental activation of the immune system. Previous stud-
ies report increased NR2A mRNA in the hippocampus of adult 
rats (7–8 weeks of age) exposed postnatally (at 2 weeks of age) 
to polyI:C (49) or the bacterial mimic LPS (50), suggesting that 
this NMDAR2A response to immune activation can even occur 
if the inflammation occurred after birth. This demonstrates that 
the mechanisms that govern NR2A expression in adulthood are 
potentially vulnerable to long-lasting effects of inflammation, 
regardless of the precise timing of inflammatory stress. In con-
trast to our lack of change in NR1 mRNA in the hippocampus, 
previous studies have reported ~20% reduced NR1 mRNA in the 
hippocampus of polyI:C mouse offspring exposed to late MIA, 
but not early MIA (13). Our data in rats suggest that polyI:C treat-
ment during gestation may not affect NR1 gene expression to the 
same extent or as consistently as it does NR2A gene expression in 
the hippocampus. These variable findings could be due to subtle 
differences in the timing of vulnerable neurodevelopmental 
epochs, or species differences.
Our results show that the CA1 subregion exhibited increased 
NR2A mRNA and increased NR2A binding and NR2A:NR2B 
ratio in the apical dendritic region (afferent) in polyI:C offspring, 
regardless of gestational timing of MIA and offspring sex. This 
suggests that synaptic input coming from CA3, which is criti-
cally dependant on NMDAR function for learning and memory 
(Schaffer collaterals), is significantly changed after developmental 
immune activation. Indeed, increases in NR2A:NR2B ratio 
reduces both long-term potentiation and long-term depression 
in the CA3-to-CA1 circuitry [see Ref. (38) for details], limiting 
plasticity and making it more difficult to learn and remember. Our 
present findings therefore suggest that polyI:C offspring have asso-
ciated molecular alterations in CA1 that perhaps would produce 
longer term memory retrieval deficits, consistent with long-term 
memory deficits found in adult polyI:C rat offspring (26).
We find localized increases in NMDAR binding in the Cg of 
polyI:C offspring, suggesting that MIA can elicit long-lasting 
changes in NMDAR expression within cortical regions of adult 
offspring, regardless of sex or gestational timing of MIA. 
Although systemic MK-801 did not alter locomotion in polyI:C 
offspring in our previous studies (30), other studies have reported 
FigUre 7 | N-methyl-d-aspartate receptor-related mRNA alterations in cortex, hippocampus, and striatum from male adult offspring exposed to vehicle (control; 
black) or polyI:C (gray) during early (GD10) or late (GD19) gestation. In situ hybridization was used to quantify NR1 mRNA (GRIN1; a,B) and NR2A mRNA (GRIN2A; 
c,D). Male polyI:C offspring had (a) no change in NR1 mRNA overall in any quantified region, but (c) significantly increased NR2A mRNA in cortex and 
hippocampus. (B) Male polyI:C offspring had significantly elevated NR1 mRNA in, the striatal subregion, AS. (D) PolyI:C offspring had significantly increased NR2A 
mRNA, in the hippocampal subregions, DG, and CA1. Bars represent mean ± SEM (n = 25–28 rats per group). DG, dentate gyrus; CA3, cornu ammonis 3; CA1, 
cornu ammonis 1; DS, dorsal striatum; AC, nucleus accumbens core; AS, nucleus accumbens shell (*p < 0.05, **p < 0.01).
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both increased (18) and decreased (19–21) locomotion in polyI:C 
offspring in response to systemic MK-801. The mechanism by 
which MK-801 elicits behavioral changes, and the contribution 
of other neurotransmitter systems, is unclear (51–54). Although 
the increased NMDARs in the cingulate may not be sufficient to 
elicit consistent MK-801 locomotion alterations in all cohorts, it 
may impact cognition dependent on Cg. Indeed, previous stud-
ies report increased glutamatergic processes (55) and NMDAR 
channel binding in anterior (42) and posterior (56) Cg of people 
with schizophrenia.
We found some interesting changes within the striatal brain 
areas examined. Our current investigation of exaggerated molec-
ular changes in striatal NMDAR of males appears to align with 
our previous behavioral investigation that showed that male, but 
not female, polyI:C rat offspring exhibit sensorimotor gating 
deficits (30). Our current molecular data shows that male, but 
not female, polyI:C offspring had increased NMDAR channel 
binding in the striatum, and elevated NR2A binding in both the 
cortex and striatum. Given that these molecular and behavioral 
alterations were exaggerated in male polyI:C offspring, one 
interpretation would be that these cortical and striatal changes 
contribute to the sensorimotor gating deficits that male polyI:C 
offspring exhibit at adulthood. However, further research is 
needed to elucidate how MIA-induced changes in NR2A-rich 
NMDARs are modified by sex and how NMDARs may contrib-
ute to sensorimotor gating function. In the present study, the 
coordinated increase in striatal NR2A and NMDAR channel 
binding in male polyI:C offspring indicates they potentially 
have increased NR2A-rich NMDARs in the striatum. In normal 
rodents, the “indirect” striatopallidal pathway is primarily medi-
ated by NR1–NR2A-rich NMDARs, while the direct “striato-
nigral–entopeduncular” pathway is mediated by NR1–NR2B 
rich NMDARs (57–59). The changes in NMDARs in the MIA 
model could suggest more activity in the indirect striatopallidal 
pathway, which is also known to be enriched in D2 receptors. 
However, how the striatal changes found here map onto these 
distinct striatal pathways needs to be determined. PolyI:C off-
spring show increased dopamine turnover and reduced D2-like 
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